Case Investigations

Harsco Corporation

January 24, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Harsco Corporation (“Harsco or the “Company”) (NYSE: HSC).  Investors who purchased Harsco common stock may be affected.

Interface, Inc.

January 23, 2020– Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Interface, Inc. (“Interface or “Company”) (NASDAQ: TILE).  Investors who purchased Interface securities may be affected.

Yext, Inc.

December 9, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Yext, Inc. (“Yext” or the “Company”) (NYSE: YEXT), a Search Experience Cloud company.

Elastic N.V.

December 9, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Elastic N.V. (“Elastic or the “Company”) (NYSE: ESTC), a data analytics provider.

Brooks Automation, Inc.

December 4, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Brooks Automation, Inc. (“Brooks Automation” or the “Company”) (NASDAQ: BRKS).

BJ's Wholesale Club

November 21, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors who purchased shares of BJ’s Wholesale Club Holdings, Inc. (“BJ’s” or the “Company”) (NYSE: BJ).

Monolithic Power Systems, Inc.

October 10, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Monolithic Power Systems, Inc. (“Monolithic” or the “Company”) (Nasdaq: MPWR).

Jumia Technologies AG

October 8, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased American Depository Shares of Jumia Technologies AG (“Jumia” or the “Company”) (NYSE: JMIA), a pan-African e-commerce platform which connects sellers with consumers.

Minerva Neurosciences, Inc.

October 1, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders.